Should Heritable Gene Editing Be Used on Humans?
By Marcy Darnovsky & George Church,
Wall Street Journal
| 04. 10. 2016
"YES" by George Church; "NO" by Marcy Darnovsky
The development of technology that allows human genes to be edited has stirred tremendous excitement about the potential for treating debilitating and life-threatening diseases. The technology could lead to drugs that would treat cancers and other diseases that currently are incurable.
But another facet of this breakthrough has many scientists and others worried: the possibility that the genetic makeup of sperm and eggs could be edited so that diseases that can be inherited won’t be passed on to children yet to be born. One concern is that gene editing that affects future generations, not just an individual, is too risky given our still incomplete understanding of the human genome and how changes might affect it. Another is that the ability to edit heritable traits could result in so-called designer babies, with parents choosing traits such as intelligence or physical characteristics.
Others say we can meet those challenges, and the potential benefits are too great to pass up.
George Church, professor of genetics at Harvard Medical School, favors a careful exploration of the potential of heritable gene editing. Marcy Darnovsky, executive...
Related Articles
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
Alice Wong, founder of the Disability Visibility Project, MacArthur Genius, liberationist, storyteller, writer, and friend of CGS, died on November 14. Alice shone a bright light on pervasive ableism in our society. She articulated how people with disabilities are limited not by an inability to do things but by systemic segregation and discrimination, the de-prioritization of accessibility, and the devaluation of their lives.
We at CGS learned so much from Alice about disability justice, which goes beyond rights...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...